Loading
Latest filing published 17 Jul 2026 for Eupraxia Pharmaceuticals Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Helen Thackray appears in our data through filings on Eupraxia Pharmaceuticals Inc. shares, published by SEDI. In total, 4 filings cover trades dated from 3 July 2026 to 13 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 17 July 2026, the filings show a share grant in Eupraxia Pharmaceuticals Inc. Filings reach the SEDI feed a median of 9 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations